Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Raleigh Reporter.
Press releases published on June 2, 2025
Silver Collection in Huntersville Hosts Family Fun Night to Celebrate Community and Connection
EIN Presswire
·
June 2, 2025
Silver Collection at Waterford is hosting a free and lively Family Fun Night on Fri, June 13th, from4-7 p.m. at 11920 Joleen Court, Huntersville, NC. HUNTERSVILLE, NC, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- At the heart of the Silver …
OutdoorAdventures.pro Launches Free Membership Program for Qualifying Outdoor Service Providers
EIN Presswire
·
June 2, 2025
OutdoorAdventures.pro now offers free memberships to qualified outdoor service providers. Apply today at www.outdooradventures.pro/join. CHARLOTTE, NC, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- OutdoorAdventures.pro, a leading digital platform …
The Jobs-to-be-Done Pyramid™: A Breakthrough Framework for Strategy, Linking Function, Emotion and Identity
EIN Presswire
·
June 2, 2025
The Jobs-to-be-Done Pyramid™ is a new model for product strategy, mapping customer motivation across domains of function, emotion, and identity. CHAPEL HILL, NC, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- In a bold leap forward for innovation …
Raybow USA Launches New Website
EIN Presswire
·
June 2, 2025
The New Look and Functionality Enhance Customer Interactions --From Molecule to Market. BREVARD, NC, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Raybow USA in Brevard, NC, proudly announces a completely new look for its website. Current and …
Alpha Modus to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented by Maxim Group LLC on Wednesday June 4th at 3:30 p.m. EDT
GlobeNewswire
·
June 2, 2025
CORNELIUS, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (NASDAQ: AMOD), an emerging leader in AI-driven retail technology, that Company CEO William Alessi and Chief Sales Officer Chris Chumas has been invited to present at the “2025 …
Children’s Home Society of North Carolina Celebrates Family Reunification Month and the Power of Second Chances
GlobeNewswire
·
June 2, 2025
Greensboro, North Carolina, June 02, 2025 (GLOBE NEWSWIRE) -- This June, Children’s Home Society of North Carolina (CHS) proudly joins organizations nationwide in celebrating National Reunification Month, a time to honor the dedication of families who work …
DP World Deepens Latin America Ties by Joining Regional Port Leadership Body
GlobeNewswire
·
June 2, 2025
CHARLOTTE, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- DP World, a global leader in logistics and supply chain solutions, has joined the Inter-American Committee on Ports (CIP) of the Organization of American States (OAS) as an associate member, reinforcing …
FDA expands XENOVIEW® indication to include children from six years of age
GlobeNewswire
·
June 2, 2025
DURHAM, NC and LONDON, June 02, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging ("MRI") of the lungs, announces that the …
Alpha Modus Holdings, Inc. CEO Affiliates To Exchange Preferred Stock for Common Stock, Demonstrating Confidence in Near Future Outlook
GlobeNewswire
·
June 2, 2025
CORNELIUS, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (NASDAQ: AMOD), a pioneer in AI-driven retail technology, today announced that CEO William Alessi’s affiliated family trusts have agreed to voluntarily exchange a substantial …
Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3
GlobeNewswire
·
June 2, 2025
DURHAM, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced that its abstract on the V007 …
Opus Genetics Announces LYNX-2 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients with Visual Disturbances Under Mesopic, Low-Contrast Conditions
GlobeNewswire
·
June 2, 2025
Study met primary endpoint of ≥15-letter (≥3-line) gain in mesopic low contrast distance visual acuity in comparison to placebo Phase 3 study showed patient-reported functional benefit in treating significant, chronic night driving impairment in …
BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
GlobeNewswire
·
June 2, 2025
RESEARCH TRIANGLE PARK, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that new data on oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) will be …
Highwoods Provides Leasing Update
GlobeNewswire
·
June 2, 2025
2nd Gen Leasing Activity Continues to be Strong Over 750,000 SF of Leases Signed to Date in Second Quarter Includes over 300,000 SF of New Leases RALEIGH, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) announced it has …
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
GlobeNewswire
·
June 2, 2025
YUTREPIA now available to be prescribed to patients via specialty pharmacies FDA approved YUTREPIA on May 23, 2025 Court denies United Therapeutics’ request for preliminary injunction and a temporary restraining order, clearing the path for full commercial …